STATIN USE IS ASSOCIATED WITH REDUCED INCIDENT CIRRHOSIS IN PATIENTS WITH ALCOHOL USE DISORDER AND HYPERLIPIDEMIA

被引：0
|
作者：
Przybyszewski, Eric [1 ]
Vannier, Augustin [1 ,2 ]
Diaz, Paige McLean [1 ,2 ]
Mahle, Rachael [2 ]
Tsai, Stephanie [2 ]
Shay, Jessica [1 ,2 ]
Patel, Suraj J. [2 ]
Chung, Raymond T. [1 ]
Schaefer, Esperance [1 ,2 ]
Goodman, Russell P. [1 ,2 ]
Luther, Jay [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA USA
[2] Massachusetts Gen Hosp, MGH Alcohol Liver Ctr, Boston, MA USA
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3192
引用
收藏
页码：S993 / S993
页数：1
相关论文
共 50 条
  • [1] Psychotherapy for Alcohol Use Disorder Is Associated With Reduced Risk of Incident Alcohol-Associated Liver Disease
    Vannier, Augustin G. L.
    Przybyszewski, Eric M.
    Shay, Jessica
    Patel, Suraj J.
    Schaefer, Esperance
    Goodman, Russell P.
    Luther, Jay
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (06) : 1571 - 1580
  • [2] ALCOHOL USE DISORDER TREATMENT IS ASSOCIATED WITH REDUCED DECOMPENSATION EVENTS IN VETERANS WITH CIRRHOSIS
    Rogal, Shari S.
    Youk, Ada
    Zhang, Hongwei
    Gellad, Walid
    Fine, Michael J.
    Good, Chester
    Chartier, Maggie
    DiMartini, Andrea F.
    Morgan, Timothy R.
    Bataller, Ramon
    Kraemer, Kevin
    HEPATOLOGY, 2019, 70 : 817A - 817A
  • [3] ALCOHOL USE DISORDER TREATMENT AND SUBSEQUENT MORTALITY AMONG PATIENTS WITH CIRRHOSIS AND ALCOHOL USE DISORDER
    Alexandre, Wheytnie
    Haseeb, Muhammad
    Agbalajobi, Olufunso M.
    Zhang, Grace Yuan
    Jonassaint, Naudia L.
    Bataller, Ramon
    Rogal, Shari S.
    HEPATOLOGY, 2020, 72 : 150A - 151A
  • [4] Systematic review: Interventions for alcohol use disorder in patients with cirrhosis or alcohol-associated hepatitis
    Oldroyd, Christopher
    Greenham, Olivia
    Martin, Graham
    Allison, Michael
    Notley, Caitlin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (08) : 763 - 773
  • [5] Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis
    Rabiee, Anahita
    Mahmud, Nadim
    Falker, Caroline
    Garcia-Tsao, Guadalupe
    Taddei, Tamar
    Kaplan, David E.
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (04)
  • [6] Pituitary Volumes Are Reduced in Patients With Alcohol Use Disorder
    Gurok, Mehmet Gurkan
    Tabara, Mehmet Fatih
    Koc, Mustafa
    Saritoy, Sumeyra
    Baykara, Sema
    Atmaca, Murad
    ALCOHOL AND ALCOHOLISM, 2023, 58 (01): : 107 - 112
  • [7] Gender Disparities in Alcohol Use Disorder Treatment Among Privately Insured Patients with Alcohol-Associated Cirrhosis
    Mellinger, Jessica L.
    Fernandez, Anne
    Shedden, Kerby
    Winder, G. Scott
    Fontana, Robert J.
    Volk, Michael L.
    Blow, Frederic C.
    Lok, Anna S. F.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 (02) : 334 - 341
  • [8] Demographic and clinical characteristics associated with utilization of alcohol use disorder treatment in a multicenter study of patients with alcohol-associated cirrhosis
    Luk, Jeremy W.
    Ha, Nghiem B.
    Shui, Amy M.
    Snyder, Hannah R.
    Batki, Steven L.
    Ostacher, Michael J.
    Monto, Alexander
    Wong, Robert J.
    Cheung, Ramsey
    Parekh, Priti
    Hua, William
    Tompkins, D. Andrew
    Fakadej, Taylor
    Haight, Christina G.
    Liao, Meimei
    Khalili, Mandana
    Satre, Derek D.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2025, 49 (01): : 244 - 255
  • [9] Statin use is associated with reduced mortality in COPD
    Soyseth, V.
    Brekke, P. H.
    Smith, P.
    Omland, T.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (02) : 279 - 283
  • [10] Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation
    Arab, Juan Pablo
    Izzy, Manhal
    Leggio, Lorenzo
    Bataller, Ramon
    Shah, Vijay H.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2022, 19 (01) : 45 - 59
12345